{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T06:41:05Z","timestamp":1789713665405,"version":"4.0.1"},"reference-count":36,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2015]]},"DOI":"10.1536\/ihj.14-411","type":"journal-article","created":{"date-parts":[[2015,6,23]],"date-time":"2015-06-23T22:08:45Z","timestamp":1435097325000},"page":"421-427","source":"Crossref","is-referenced-by-count":20,"title":["Association Between Genetic Variation in the &lt;i&gt;SCN10A&lt;\/i&gt; Gene and Cardiac Conduction Abnormalities in Patients With Hypertrophic Cardiomyopathy"],"prefix":"10.1536","volume":"56","author":[{"given":"Chiharuko","family":"Iio","sequence":"first","affiliation":[{"name":"Department of Cardiology, Pulmonology, Hypertension & Nephrology, Ehime University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiyoshi","family":"Ogimoto","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Pulmonology, Hypertension & Nephrology, Ehime University Graduate School of Medicine"},{"name":"Cardiovascular Division, Department of Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Nagai","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Pulmonology, Hypertension & Nephrology, Ehime University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Pulmonology, Hypertension & Nephrology, Ehime University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuji","family":"Inoue","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Pulmonology, Hypertension & Nephrology, Ehime University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhisa","family":"Nishimura","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Pulmonology, Hypertension & Nephrology, Ehime University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruyoshi","family":"Uetani","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Pulmonology, Hypertension & Nephrology, Ehime University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Okayama","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Pulmonology, Hypertension & Nephrology, Ehime University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Okura","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Pulmonology, Hypertension & Nephrology, Ehime University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Shigematsu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Pulmonology, Hypertension & Nephrology, Ehime University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuharu","family":"Tabara","sequence":"additional","affiliation":[{"name":"Department of Geriatric Medicine, Ehime University Graduate School of Medicine"},{"name":"Center for Genomic Medicine, Kyoto University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhiko","family":"Kohara","sequence":"additional","affiliation":[{"name":"Department of Geriatric Medicine, Ehime University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuro","family":"Miki","sequence":"additional","affiliation":[{"name":"Department of Geriatric Medicine, Ehime University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mareomi","family":"Hamada","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Uwajima City Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitsuo","family":"Higaki","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Pulmonology, Hypertension & Nephrology, Ehime University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation 1995; 92: 785-9.","DOI":"10.1161\/01.CIR.92.4.785"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Maron BJ, Maron MS. Hypertrophic cardiomyopathy. Lancet 2013; 381: 242-55.","DOI":"10.1016\/S0140-6736(12)60397-3"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Otsuka H, Arimura T, Abe T, <i>et al<\/i>. Prevalence and distribution of sarcomeric gene mutations in Japanese patients with familial hypertrophic cardiomyopathy. Circ J 2012; 76: 453-61.","DOI":"10.1253\/circj.CJ-11-0876"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Kubo T, Kitaoka H, Okawa M, <i>et al<\/i>. Genetic screening and double mutation in Japanese patients with hypertrophic cardiomyopathy. Circ J 2011; 75: 2654-9.","DOI":"10.1253\/circj.CJ-10-1314"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Ogimoto A, Okayama H, Nagai T, <i>et al<\/i>. Impact of synergistic polymorphisms in adrenergic receptor-related genes and cardiovascular events in patients with dilated cardiomyopathy. Circ J 2012; 76: 2003-8.","DOI":"10.1253\/circj.CJ-11-1014"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Fukutomi M, Tanaka N, Uchinoumi H, <i>et al<\/i>. Japanese patients with Fabry disease predominantly showing cardiac and neurological manifestation with novel missense mutation: R220P. J Cardiol 2013; 62: 63-9.","DOI":"10.1016\/j.jjcc.2013.02.012"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Muhib S, Fujino T, Sato N, Hasebe N. Epicardial adipose tissue is associated with prevalent atrial fibrillation in patients with hypertrophic cardiomyopathy. Int Heart J 2013; 54: 297-303.","DOI":"10.1536\/ihj.54.297"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Okamoto R, Hirashiki A, Cheng XW, <i>et al<\/i>. Usefulness of serum cardiac troponins T and I to predict cardiac molecular changes and cardiac damage in patients with hypertrophic cardiomyopathy. Int Heart J 2013; 54: 202-6.","DOI":"10.1536\/ihj.54.202"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Kim SH, Kim SO, Han S, <i>et al<\/i>. Long-term comparison of apical versus asymmetric hypertrophic cardiomyopathy. Int Heart J 2013; 54: 207-11.","DOI":"10.1536\/ihj.54.207"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Ogimoto A, Hamada M, Nakura J, Miki T, Hiwada K. Relation between angiotensin-converting enzyme II genotype and atrial fibrillation in Japanese patients with hypertrophic cardiomyopathy. J Hum Genet 2002; 47: 184-9.","DOI":"10.1007\/s100380200021"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Nagai T, Ogimoto A, Okayama H, <i>et al<\/i>. A985G polymorphism of the endothelin-2 gene and atrial fibrillation in patients with hypertrophic cardiomyopathy. Circ J 2007; 71: 1932-6.","DOI":"10.1253\/circj.71.1932"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Ogimoto A, Okayama H, Nagai T, <i>et al<\/i>. Pharmacogenetic interactions between Angiotensin-converting enzyme insertion\/deletion polymorphism and response to cibenzoline in patients with hypertrophic obstructive cardiomyopathy. J Cardiovasc Pharmacol 2010; 55: 506-10.","DOI":"10.1097\/FJC.0b013e3181d8bc4b"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Olsson SB, Cotoi S, Varnauskas E. Monophasic action potential and sinus rhythm stability after conversion of atrial fibrillation. Acta Med Scand 1971; 190: 381-7.","DOI":"10.1111\/j.0954-6820.1971.tb07446.x"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Soliman EZ, Prineas RJ, Case LD, Zhang ZM, Goff DC Jr. Ethnic distribution of ECG predictors of atrial fibrillation and its impact on understanding the ethnic distribution of ischemic stroke in the Atherosclerosis Risk in Communities (ARIC) study. Stroke 2009; 40: 1204-11.","DOI":"10.1161\/STROKEAHA.108.534735"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Cheng S, Keyes MJ, Larson MG, <i>et al<\/i>. Long-term outcomes in individuals with prolonged PR interval or first-degree atrioventricular block. JAMA 2009; 301: 2571-7.","DOI":"10.1001\/jama.2009.888"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Schnabel RB, Sullivan LM, Levy D, <i>et al<\/i>. Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study. Lancet 2009; 373: 739-45.","DOI":"10.1016\/S0140-6736(09)60443-8"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Wolf PA, Dawber TR, Thomas HE, Kannel WB. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study. Neurology 1978; 28: 973-7.","DOI":"10.1212\/WNL.28.10.973"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Krahn AD, Manfreda J, Tate RB, Mathewson FA, Cuddy TE. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med 1995; 98: 476-84.","DOI":"10.1016\/S0002-9343(99)80348-9"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Ott A, Breteler MM, de Bruyne MC, van Harskamp F, Grobbee DE, Hofman A. Atrial fibrillation and dementia in a population-based study. The Rotterdam Study. Stroke 1997; 28: 316-21.","DOI":"10.1161\/01.STR.28.2.316"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Benjamin EJ, Wolf PA, D\u2019Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998; 98: 946-52.","DOI":"10.1161\/01.CIR.98.10.946"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Wu JT, Dong JZ, Sang CH, Tang RB, Ma CS. Prolonged PR interval and risk of recurrence of atrial fibrillation after catheter ablation. Int Heart J 2014; 55: 126-30.","DOI":"10.1536\/ihj.13-231"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Pfeufer A, van Noord C, Marciante KD, <i>et al<\/i>. Genome-wide association study of PR interval. Nat Genet 2010; 42: 153-9.","DOI":"10.1038\/ng.517"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Chambers JC, Zhao J, Terracciano CM, <i>et al<\/i>. Genetic variation in <i>SCN10A<\/i> influences cardiac conduction. Nat Genet 2010; 42: 149-52.","DOI":"10.1038\/ng.516"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Holm H, Gudbjartsson DF, Arnar DO, <i>et al<\/i>. Several common variants modulate heart rate, PR interval and QRS duration. Nat Genet 2010; 42: 117-22.","DOI":"10.1038\/ng.511"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Denny JC, Ritchie MD, Crawford DC, <i>et al<\/i>. Identification of genomic predictors of atrioventricular conduction: using electronic medical records as a tool for genome science. Circulation 2010; 122: 2016-21.","DOI":"10.1161\/CIRCULATIONAHA.110.948828"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Ritchie MD, Denny JC, Zuvich RL, <i>et al<\/i>. Genome- and phenome-wide analysis of cardiac conduction identifies markers of arrhythmia risk. Circulation 2013; 127: 1377-85.","DOI":"10.1161\/CIRCULATIONAHA.112.000604"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Devor M. Sodium channels and mechanisms of neuropathic pain. J Pain 2006; 7: S3-S12. (Review)","DOI":"10.1016\/j.jpain.2005.09.006"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Facer P, Punjabi PP, Abrari A, <i>et al<\/i>. Localisation of <i>SCN10A<\/i> gene product Na(v)1.8 and novel pain-related ion channels in human heart. Int Heart J 2011; 52: 146-52.","DOI":"10.1536\/ihj.52.146"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Verkerk AO, Remme CA, Schumacher CA, <i>et al<\/i>. Functional Nav1.8 channels in intracardiac neurons: the link between <i>SCN10A <\/i>and cardiac electrophysiology. Circ Res 2012; 111: 333-43.","DOI":"10.1161\/CIRCRESAHA.112.274035"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Yang T, Atack TC, Stroud DM, Zhang W, Hall L, Roden DM. Blocking Scn10a channels in heart reduces late sodium current and is antiarrhythmic. Circ Res 2012; 111: 322-32.","DOI":"10.1161\/CIRCRESAHA.112.265173"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Sotoodehnia N, Isaacs A, de Bakker PI, <i>et al<\/i>. Common variants in 22 loci are associated with QRS duration and cardiac ventricular conduction. Nat Genet 2010; 42: 1068-76.","DOI":"10.1038\/ng.716"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Delaney JT, Muhammad R, Shi Y, <i>et al<\/i>. Common <i>SCN10A<\/i> variants modulate PR interval and heart rate response during atrial fibrillation. Europace 2014; 16: 485-90.","DOI":"10.1093\/europace\/eut278"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Qi B, Wei Y, Chen S, <i>et al<\/i>. Nav1.8 channels in ganglionated plexi modulate atrial fibrillation inducibility. Cardiovasc Res 2014; 102: 480-6.","DOI":"10.1093\/cvr\/cvu005"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Cecchi F, Montereggi A, Olivotto I, Marconi P, Dolara A, Maron BJ. Risk for atrial fibrillation in patients with hypertrophic cardiomyopathy assessed by signal averaged P wave duration. Heart 1997; 78: 44-9.","DOI":"10.1136\/hrt.78.1.44"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Olivotto I, Cecchi F, Casey SA, Dolara A, Traverse JH, Maron BJ. Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy. Circulation 2001; 104: 2517-24.","DOI":"10.1161\/hc4601.097997"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Roberts R, Stewart AF. Genes and coronary artery disease: where are we? J Am Coll Cardiol 2012; 60: 1715-21. (Review)","DOI":"10.1016\/j.jacc.2011.12.062"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T14:23:42Z","timestamp":1498227822000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/56\/4\/56_14-411\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.14-411","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}